Literature DB >> 30306023

Multimodality Imaging of Left Ventricular Clefts in an Asymptomatic Teenager.

Chiara Bencini1, Giovanni Corrado2, Claudia Borghi3, Stefano Carugo1.   

Abstract

Left ventricular clefts (LVCs) are defined as deep, tight blood-filled invaginations within the ventricular myocardium localized predominantly in the basal posterior septum and LV-free wall. Usually, they are asymptomatic and incidentally discovered during diagnostic imaging procedures. LVC has been reported both in healthy volunteers and in patients affected with hypertrophic cardiomyopathy. Clinicians should be able to recognize LVC and to distinguish this entity from other myocardial wall defects with different pathological profile and clinical significance. We describe a case of multimodality imaging of multiple septal myocardial clefts in an asymptomatic teenager.

Entities:  

Keywords:  Cardiac magnetic resonance; echocardiography; myocardial cleft

Year:  2018        PMID: 30306023      PMCID: PMC6172879          DOI: 10.4103/jcecho.jcecho_10_18

Source DB:  PubMed          Journal:  J Cardiovasc Echogr        ISSN: 2211-4122


INTRODUCTION

Left ventricular clefts (LVCs) are congenital fissure-like protrusions penetrating more than 50% of the thickness of adjoining compacted myocardium which does not exceed beyond the myocardial margin.[12] They have been reported in 5%–6% of the general population[1] and are well detected by cardiac computerized tomography (CT) or magnetic resonance (MR); echocardiography is less sensitive and can fail their identification.[3] LVC are most commonly located at the basal to mid inferoseptal and anteroseptal segment of the left ventricle, less commonly at mid inferior and apical septal segments.[3] They contract normally without local hypokinesia or dyskinesia, usually obliterate during systole and are oriented approximately perpendicular to the long axis of the left ventricle.[1] Some authors call this entity with different names such as recesses or crypts. The etiology of these myocardial structural defects is unclear. Some authors suggested that clefts represent early pathological alterations of the myocardium in patients with hypertrophic cardiomyopathy (HCM) mutations who had not yet developed echocardiographic evidence of hypertrophy, so they could represent a distinctive pathological expression of HCM.[3] However, in large retrospective series in a general population studied with cardiac CT, LVC was found in 6.7% of patients who exhibited a good prognosis. As a matter of fact, on follow-up, there was no significant difference compared to the control group without LVC in the incidence of major adverse cardiac events or stroke.[3] LVC must be distinguished from ventricular congenital aneurysm and ventricular diverticula, which have different histological and morphological characteristics and outcomes. Congenital left ventricular diverticulum is a malformation characterized by saccular protrusion extending beyond the borders of the myocardial margin, has a narrow communication with LV, and displays normal contraction.[34] Congenital left ventricular aneurysms have a wide connection with the LV, are fibrotic, and usually akinetic or dyskinetic.[5] Congenital left ventricular diverticula and aneurysms have potentially harmful and even lethal complications; furthermore, they are frequently associated with structural cardiac anomalies.[45]

CASE REPORT

An asymptomatic 17-year-old woman underwent echocardiogram at our laboratory because of heart murmur. Rest electrocardiogram was normal. On family history, her father was affected by HCM. On echocardiography, we found normal volume, mass, and systodiastolic function of the LV. The right ventricle was normal too and no valve disease was detected. Nevertheless, we found two deep recesses in the basal and medium third of the interventricular septum containing luminal blood in diastole with complete obliteration in systole [Figure 1]. No interventricular shunt was found. The septal myocardium appeared to be compact, and no local hypertrophy was found. A cardiac MR confirmed the presence of two clefts of the septal myocardium penetrating more than 50% of the thickness of the septum, the distal one being bilobated [Figures 2 and 3]. The surrounding myocardium showed a normal contractility, as normal was the global systolic function of the left ventricle [Video 1]. Neither areas of fibrosis after gadolinium infusion nor markers of HCM were detected. The patient and the parents were reassured about the benign nature of these findings. Nevertheless, since some authors suggested that LVC may be more prevalent in HCM mutation carriers without hypertrophy[3] and given that the father of the patient was affected with a clinically evident form of HCM, a genetic counseling was suggested.
Figure 1

Two-dimensional transthoracic echo diastolic frames. Panel A: modified apical 4c chamber view. Panel B: subcostal view. White arrows indicate the entrance of the left ventricular clefts. In the subcostal view, both the basal and the more apical clefts are clearly visible. The more apical cleft bifurcates in its final part toward the right side of the interventricular septum. In 4-chamber view, only the most apical cleft is visible. During systole, do to myocardial contraction, blood is squeezed in the left ventricle and clefts are emptied and no more appreciable. LA = Left atrium, LV = Left ventricle, RV = Right ventricle

Figure 2

Cardiac magnetic resonance. Fast imaging employing steady state acquisition Two-dimensional – left ventricular 4-chamber view. Two myocardial clefts (white arrows) are visible in the basal inferior interventricular septum, contained by a normally contracting myocardium. As already visible in the echo imaging, the more apical cleft (longer arrow) bifurcates in its distal portion. Abbreviations as in Figure 1

Figure 3

Cardiac magnetic resonance. Double inversion recovery. Left ventricular 4-chamber (Panel A) and short-axis view (Panel B). The bifurcated myocardial cleft in the inferior interventricular septum is depicted, contained by a normal myocardium (arrow). Abbreviations as in Figure 1

Two-dimensional transthoracic echo diastolic frames. Panel A: modified apical 4c chamber view. Panel B: subcostal view. White arrows indicate the entrance of the left ventricular clefts. In the subcostal view, both the basal and the more apical clefts are clearly visible. The more apical cleft bifurcates in its final part toward the right side of the interventricular septum. In 4-chamber view, only the most apical cleft is visible. During systole, do to myocardial contraction, blood is squeezed in the left ventricle and clefts are emptied and no more appreciable. LA = Left atrium, LV = Left ventricle, RV = Right ventricle Cardiac magnetic resonance. Fast imaging employing steady state acquisition Two-dimensional – left ventricular 4-chamber view. Two myocardial clefts (white arrows) are visible in the basal inferior interventricular septum, contained by a normally contracting myocardium. As already visible in the echo imaging, the more apical cleft (longer arrow) bifurcates in its distal portion. Abbreviations as in Figure 1 Cardiac magnetic resonance. Double inversion recovery. Left ventricular 4-chamber (Panel A) and short-axis view (Panel B). The bifurcated myocardial cleft in the inferior interventricular septum is depicted, contained by a normal myocardium (arrow). Abbreviations as in Figure 1 LVC have been reported both in the general healthy population[1] and in HCM mutation carriers without LV hypertrophy.[3] They must be correctly identified and diagnosed and should not be misinterpreted as ventricular diverticula or congenital aneurysms. Up to now, there are no robust data on the clinical significance of myocardial clefts in otherwise normal individuals. Nevertheless, on the basis of the existing literature, such individuals should be reassured and LVC should probably be regarded as incidental variants of myocardial structure unlikely to require further investigation and with an overall good prognosis on follow-up.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Congenital left ventricular diverticula.

Authors:  M S Tullu; P Vaideeswar; C T Deshmukh
Journal:  Int J Cardiol       Date:  2000-05-31       Impact factor: 4.164

2.  Left ventricular sub-valvar mitral aneurysms.

Authors:  Henning J Du Toit; Ulrich O Von Oppell; John Hewitson; John Lawrenson; John Davies
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

3.  Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance.

Authors:  Bengt Johansson; Alicia M Maceira; Sonya V Babu-Narayan; James C Moon; Dudley J Pennell; Philip J Kilner
Journal:  J Am Coll Cardiol       Date:  2007-09-10       Impact factor: 24.094

4.  Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.

Authors:  Tjeerd Germans; Arthur A M Wilde; Pieter A Dijkmans; Wenxia Chai; Otto Kamp; Yigal M Pinto; Albert C van Rossum
Journal:  J Am Coll Cardiol       Date:  2006-11-28       Impact factor: 24.094

5.  Prevalence of inferobasal myocardial crypts among patients referred for cardiovascular magnetic resonance.

Authors:  Joanna Petryka; A John Baksi; Sanjay K Prasad; Dudley J Pennell; Philip J Kilner
Journal:  Circ Cardiovasc Imaging       Date:  2014-02-07       Impact factor: 7.792

  5 in total
  1 in total

1.  Multimodality Imaging Diagnosis of Multiple Ventricular Thrombosis and Massive Stroke after Gemcitabine and Cisplatin Chemotherapy for Urothelial Cancer.

Authors:  Pier Paolo Bassareo; Daniele Cocco; Christian Cadeddu; Giuseppe Mercuro
Journal:  J Cardiovasc Echogr       Date:  2019 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.